Published 20 hours ago • loading... • Updated 20 hours ago

Neumora Therapeutics Announces Initiation of Phase 1 Clinical Study of M4 Positive Allosteric ...

NMRA-861 has potential best-in-class pharmacology, which may enable a more favorable therapeutic profile

All

Left

Center

Right

NMRA-861 has potential best-in-class pharmacology, which may enable a more favorable therapeutic profile

20 hours ago

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Total News Sources1

Leaning Left0Leaning Right0Center1Last Updated20 hours agoBias Distribution

100% Center

100% Center

To view factuality data please Upgrade to Premium

To view ownership data please Upgrade to Vantage

Hastings Tribune broke the news in 20 hours ago on Wednesday, July 9, 2025.

Sources are mostly out of (0)